These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Kinetics of productive and latent HIV infection in lymphatic tissue and peripheral blood during triple-drug combination therapy with or without additional interleukin-2. Stellbrink HJ, Hufert FT, Tenner-Racz K, Lauer J, Schneider C, Albrecht H, Racz P, van Lunzen J. Antivir Ther; 1998; 3(4):209-14. PubMed ID: 10682140 [Abstract] [Full Text] [Related]
3. Pilot study of a combination of highly active antiretroviral therapy and cytokines to induce HIV-1 remission. Lafeuillade A, Poggi C, Chadapaud S, Hittinger G, Chouraqui M, Pisapia M, Delbeke E. J Acquir Immune Defic Syndr; 2001 Jan 01; 26(1):44-55. PubMed ID: 11176268 [Abstract] [Full Text] [Related]
5. Protease inhibitor-containing regimens compared with nucleoside analogues alone in the suppression of persistent HIV-1 replication in lymphoid tissue. Ruiz L, van Lunzen J, Arno A, Stellbrink HJ, Schneider C, Rull M, Castellà E, Ojanguren I, Richman DD, Clotet B, Tenner-Racz K, Racz P. AIDS; 1999 Jan 14; 13(1):F1-8. PubMed ID: 10207538 [Abstract] [Full Text] [Related]
7. Germinal centre CD4+ T cells are an important site of HIV replication in vivo. Hufert FT, van Lunzen J, Janossy G, Bertram S, Schmitz J, Haller O, Racz P, von Laer D. AIDS; 1997 Jun 14; 11(7):849-57. PubMed ID: 9189209 [Abstract] [Full Text] [Related]
8. Quantification of HIV-1 viral load in lymphoid and blood cells: assessment during four-drug combination therapy. Tamalet C, Lafeuillade A, Fantini J, Poggi C, Yahi N. AIDS; 1997 Jun 14; 11(7):895-901. PubMed ID: 9189215 [Abstract] [Full Text] [Related]
12. Viral Reservoirs in Lymph Nodes of FIV-Infected Progressor and Long-Term Non-Progressor Cats during the Asymptomatic Phase. Eckstrand CD, Hillman C, Smith AL, Sparger EE, Murphy BG. PLoS One; 2016 Jun 14; 11(1):e0146285. PubMed ID: 26741651 [Abstract] [Full Text] [Related]
13. Activation of CD8 T cells normalizes and correlates with the level of infectious provirus in tonsils during highly active antiretroviral therapy in early HIV-1 infection. Dyrhol-Riise AM, Voltersvik P, Olofsson J, Asjö B. AIDS; 1999 Dec 03; 13(17):2365-76. PubMed ID: 10597778 [Abstract] [Full Text] [Related]
14. Rapid plasma virus and CD4+ T-cell turnover in HIV-1 infection: evidence for an only transient interruption by treatment. Stellbrink HJ, Zöller B, Fenner T, Lichtenberg G, van Lunzen J, Albrecht H, Thiele HG, Greten H. AIDS; 1996 Jul 03; 10(8):849-57. PubMed ID: 8828742 [Abstract] [Full Text] [Related]
18. Cellular proviral HIV-DNA decline and viral isolation in naïve subjects with <5000 copies/ml of HIV-RNA and >500 x 10(6)/l CD4 cells treated with highly active antiretroviral therapy. Andreoni M, Parisi SG, Sarmati L, Nicastri E, Ercoli L, Mancino G, Sotgiu G, Mannazzu M, Trevenzoli M, Tridente G, Concia E, Aceti A. AIDS; 2000 Jan 07; 14(1):23-9. PubMed ID: 10714564 [Abstract] [Full Text] [Related]
19. Comparison of virus burden in blood and sequential lymph node biopsy specimens from children infected with human immunodeficiency virus. Mueller BU, Sei S, Anderson B, Luzuriaga K, Farley M, Venzon DJ, Tudor-Williams G, Schwartzentruber DJ, Fox C, Sullivan JL, Pizzo PA. J Pediatr; 1996 Sep 07; 129(3):410-8. PubMed ID: 8804331 [Abstract] [Full Text] [Related]
20. Detection and quantification of proviral HIV-1 184 M/V in circulating CD4(+) T cells of patients on HAART with a viremia less than 1,000 copies/ml. Mohey R, Jørgensen LB, Møller BK, Black FT, Kjems J, Obel N. J Clin Virol; 2005 Dec 07; 34(4):257-67. PubMed ID: 16286049 [Abstract] [Full Text] [Related] Page: [Next] [New Search]